TECON BIOLOGY Co.LTD (SHE:002100)
China
· Delayed Price · Currency is CNY 7.84
+0.13 (1.69%)
Apr 29, 2026, 3:04 PM CST
TECON BIOLOGY Co.LTD Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 10,526 | 10,062 | 8,942 | 11,973 | 11,255 | 11,517 | Upgrade
|
| Market Cap Growth | 24.56% | 12.52% | -25.31% | 6.39% | -2.28% | 1.15% | Upgrade
|
| Enterprise Value | 13,899 | 13,435 | 12,563 | 15,378 | 14,181 | 15,091 | Upgrade
|
| Last Close Price | 7.71 | 7.37 | 6.33 | 8.48 | 7.81 | 10.06 | Upgrade
|
| PE Ratio | 51.40 | 47.77 | 14.78 | - | 40.08 | - | Upgrade
|
| Forward PE | 18.93 | 14.99 | 10.10 | 27.14 | 9.79 | 27.03 | Upgrade
|
| PS Ratio | 0.62 | 0.59 | 0.52 | 0.63 | 0.66 | 0.73 | Upgrade
|
| PB Ratio | 1.23 | 1.18 | 1.05 | 1.51 | 1.17 | 1.49 | Upgrade
|
| P/TBV Ratio | 1.64 | 1.57 | 1.38 | 2.04 | 1.48 | 1.69 | Upgrade
|
| P/FCF Ratio | 5507.13 | 5264.27 | 16.70 | 15.95 | - | - | Upgrade
|
| P/OCF Ratio | 27.64 | 26.42 | 7.70 | 6.84 | 34.31 | 7.51 | Upgrade
|
| PEG Ratio | - | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | Upgrade
|
| EV/Sales Ratio | 0.82 | 0.79 | 0.73 | 0.81 | 0.84 | 0.96 | Upgrade
|
| EV/EBITDA Ratio | 10.77 | 10.65 | 8.24 | - | 13.00 | 60.16 | Upgrade
|
| EV/EBIT Ratio | 23.05 | 22.28 | 15.36 | - | 37.55 | - | Upgrade
|
| EV/FCF Ratio | 7272.03 | 7029.17 | 23.46 | 20.49 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.75 | 0.75 | 0.76 | 0.81 | 0.77 | 0.92 | Upgrade
|
| Debt / EBITDA Ratio | 4.94 | 4.94 | 3.81 | - | 6.76 | 28.44 | Upgrade
|
| Debt / FCF Ratio | 3331.76 | 3331.76 | 12.10 | 8.52 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.46 | 0.46 | 0.40 | 0.45 | 0.35 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.12 | 3.12 | 2.21 | -7.40 | 3.12 | 14.79 | Upgrade
|
| Net Debt / FCF Ratio | 2060.09 | 2060.09 | 6.30 | 4.76 | -3.09 | -16.91 | Upgrade
|
| Asset Turnover | 0.97 | 0.97 | 1.00 | 1.05 | 0.93 | 0.96 | Upgrade
|
| Inventory Turnover | 3.01 | 3.01 | 3.30 | 3.58 | 2.72 | 2.59 | Upgrade
|
| Quick Ratio | 0.47 | 0.47 | 0.62 | 0.52 | 0.78 | 0.60 | Upgrade
|
| Current Ratio | 1.53 | 1.53 | 1.52 | 1.26 | 2.00 | 1.52 | Upgrade
|
| Return on Equity (ROE) | 3.52% | 3.52% | 7.26% | -17.29% | 2.19% | -9.53% | Upgrade
|
| Return on Assets (ROA) | 2.16% | 2.16% | 2.98% | -4.45% | 1.29% | -1.73% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.79% | 4.53% | 6.83% | -10.49% | 2.71% | -4.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 5.50% | 7.40% | -13.30% | 2.90% | -4.50% | Upgrade
|
| Earnings Yield | 2.00% | 2.09% | 6.77% | -11.39% | 2.50% | -6.10% | Upgrade
|
| FCF Yield | 0.02% | 0.02% | 5.99% | 6.27% | -9.79% | -1.91% | Upgrade
|
| Dividend Yield | 2.93% | - | 3.48% | - | 2.82% | - | Upgrade
|
| Payout Ratio | 210.13% | 210.13% | 28.65% | - | 92.90% | - | Upgrade
|
| Buyback Yield / Dilution | -2.12% | -2.12% | -1.88% | -0.95% | -21.76% | -2.13% | Upgrade
|
| Total Shareholder Return | 0.82% | -2.12% | 1.60% | -0.95% | -18.94% | -2.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.